Evan J Anderson1, Eric A F Simões2, Jim P Buttery3, Penelope H Dennehy4, Joseph B Domachowske5, Kathryn Jensen6, Jay M Lieberman7, Genevieve A Losonsky6, Ram Yogev1. 1. Children's Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Ilinois. 2. The University of Colorado School of Medicine, Children's Hospital Colorado, Aurora. 3. Royal Children's and Monash Children's Hospitals, Murdoch Children's Research Institute, Department of Paediatrics, Monash University, Melbourne, Australia. 4. Hasbro Children's Hospital and The Alpert Medical School of Brown University, Providence, Rhode Island. 5. SUNY Upstate Medical University, Department of Pediatrics, Syracuse, New York. 6. Clinical Development, MedImmune, LLC, Gaithersburg, Maryland. 7. Miller Children's Hospital, Long Beach, California.
Abstract
BACKGROUND: Human metapneumovirus (HMPV) is a significant cause of respiratory tract infections. Little is known about HMPV in children who are at high risk for lower respiratory tract infection (LRTI). METHODS: To determine the prevalence of HMPV in high-risk children and to identify HMPV risk factors, children ≤24 months with prematurity, chronic lung disease, and/or congenital cardiac disease who were hospitalized with LRTI were prospectively enrolled. Nasopharyngeal aspirates were tested for HMPV, respiratory syncytial virus (RSV), influenza A and B, and parainfluenza types 1-3. Demographics, medical history, and outcomes for those with HMPV and RSV were compared. A multivariate analysis was performed to determine HMPV risk factors. RESULTS: Over 4 years, 1126 eligible children were enrolled. Pathogens were identified in 61% of subjects. HMPV was identified in 9.0%, second to RSV (45%). Coinfection with HMPV and RSV occurred in <1% of subjects. Subjects infected with HMPV were older (8.2 vs 4.0 months, P < .001), were born more prematurely (27 vs 33 weeks, P < .001), and more commonly had chronic lung disease (59.3% vs 21.8%, P < .001) compared with subjects infected with RSV. In a multivariate analysis that compared children infected with HMPV to all others, increasing age and household exposure to children ages 6-12 were associated with an increased risk, whereas birth at older gestational age and exposure to children age >12 were associated with a decreased risk. CONCLUSIONS: HMPV was detected in 9% of high-risk children who were hospitalized with lower respiratory tract disease, representing the second most common virus in this population. Compared with all other subjects (including RSV-infected), subjects infected with HMPV were older but were born more prematurely.
BACKGROUND:Human metapneumovirus (HMPV) is a significant cause of respiratory tract infections. Little is known about HMPV in children who are at high risk for lower respiratory tract infection (LRTI). METHODS: To determine the prevalence of HMPV in high-risk children and to identify HMPV risk factors, children ≤24 months with prematurity, chronic lung disease, and/or congenital cardiac disease who were hospitalized with LRTI were prospectively enrolled. Nasopharyngeal aspirates were tested for HMPV, respiratory syncytial virus (RSV), influenza A and B, and parainfluenza types 1-3. Demographics, medical history, and outcomes for those with HMPV and RSV were compared. A multivariate analysis was performed to determine HMPV risk factors. RESULTS: Over 4 years, 1126 eligible children were enrolled. Pathogens were identified in 61% of subjects. HMPV was identified in 9.0%, second to RSV (45%). Coinfection with HMPV and RSV occurred in <1% of subjects. Subjects infected with HMPV were older (8.2 vs 4.0 months, P < .001), were born more prematurely (27 vs 33 weeks, P < .001), and more commonly had chronic lung disease (59.3% vs 21.8%, P < .001) compared with subjects infected with RSV. In a multivariate analysis that compared children infected with HMPV to all others, increasing age and household exposure to children ages 6-12 were associated with an increased risk, whereas birth at older gestational age and exposure to children age >12 were associated with a decreased risk. CONCLUSIONS:HMPV was detected in 9% of high-risk children who were hospitalized with lower respiratory tract disease, representing the second most common virus in this population. Compared with all other subjects (including RSV-infected), subjects infected with HMPV were older but were born more prematurely.
Authors: Leigh M Howard; Kathryn M Edwards; Yuwei Zhu; Carlos G Grijalva; Wesley H Self; Seema Jain; Krow Ampofo; Andrew T Pavia; Sandra R Arnold; Jonathan A McCullers; Evan J Anderson; Richard G Wunderink; Derek J Williams Journal: Clin Infect Dis Date: 2021-01-23 Impact factor: 9.079
Authors: Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Caroline B Hall; Peter G Szilagyi; Mary A Staat; Marika Iwane; Mila M Prill; John V Williams Journal: N Engl J Med Date: 2013-02-14 Impact factor: 91.245
Authors: María Luz García-García; Cristina Calvo; Cristina Rey; Beatriz Díaz; Maria Del Mar Molinero; Francisco Pozo; Inmaculada Casas Journal: PLoS One Date: 2017-03-16 Impact factor: 3.240
Authors: Nina Moe; Sidsel Krokstad; Inger Heimdal Stenseng; Andreas Christensen; Lars Høsøien Skanke; Kari Ravndal Risnes; Svein Arne Nordbø; Henrik Døllner Journal: PLoS One Date: 2017-01-17 Impact factor: 3.240
Authors: Leigh M Howard; Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Peter G Szilagyi; Mary A Staat; Daniel C Payne; John V Williams Journal: J Pediatric Infect Dis Soc Date: 2018-05-15 Impact factor: 3.164